| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 605.75B | 625.27B | 504.92B | 460.83B | 411.87B |
| Gross Profit | 233.18B | 235.30B | 182.52B | 155.05B | 134.37B |
| EBITDA | 137.10B | 148.51B | 105.00B | 85.25B | 70.77B |
| Net Income | 92.00B | 99.47B | 70.58B | 57.49B | 45.48B |
Balance Sheet | |||||
| Total Assets | 722.42B | 671.29B | 676.81B | 562.82B | 459.31B |
| Cash, Cash Equivalents and Short-Term Investments | 227.37B | 200.40B | 197.28B | 175.58B | 133.09B |
| Total Debt | 6.09B | 4.56B | 7.18B | 28.85B | 44.23B |
| Total Liabilities | 235.73B | 250.59B | 304.89B | 262.88B | 211.51B |
| Stockholders Equity | 486.57B | 420.64B | 371.87B | 299.89B | 247.72B |
Cash Flow | |||||
| Free Cash Flow | 67.20B | 49.45B | 58.15B | 55.09B | 72.94B |
| Operating Cash Flow | 92.71B | 71.23B | 96.25B | 73.91B | 81.75B |
| Investing Cash Flow | -29.71B | -21.77B | -43.46B | -12.51B | -9.95B |
| Financing Cash Flow | -40.20B | -46.47B | -35.14B | -20.96B | -4.95B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | ¥2.06T | 22.85 | 21.73% | 2.29% | -3.12% | -4.90% | |
82 Outperform | ¥3.62T | 40.51 | 53.12% | 1.11% | 12.01% | 26.66% | |
80 Outperform | ¥7.20T | 52.09 | 25.78% | 0.79% | 11.08% | 9.32% | |
79 Outperform | ¥23.78T | 41.72 | 26.01% | 1.79% | 0.49% | 6.10% | |
73 Outperform | ¥721.43B | 28.51 | 12.66% | 2.28% | 10.83% | -3.75% | |
67 Neutral | ¥1.93T | 63.71 | ― | 0.73% | -1.61% | -16.57% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |